Key insights
- Becton Dickinson (BDX) appointed Peter Menziuso as president of its interventional unit. The company recently reported strong Q2 2026 earnings, exceeding analyst expectations with an adjusted EPS of $2.90 and revenue of $4.7 billion. BD has a strong dividend history, raising it for 55 consecutive years, and a "GOOD" financial health score. This news suggests continued stability and potential growth for the company, which could positively influence investor sentiment.
FRANKLIN LAKES, N.J. - BD (NYSE:BDX) announced Monday that Peter Menziuso will become executive vice president and president of BD Interventional, effective June 1.
Menziuso joins BD from Johnson & Johnson, where he served as Company Group Chairman of Johnson & Johnson Vision, leading a $5 billion global business. His responsibilities at J&J included commercial operations, research and development, supply chain, quality, finance and medical affairs, according to a press release statement.
Menziuso has more than 30 years of experience in global healthcare leadership. At BD, he will oversee the company’s interventional business segment.
"BD Interventional has a strong track record of performance, and Peter is the right leader to build on that momentum and continue delivering results," said Tom Polen, chairman, CEO and president of BD.
BD is a medical technology company with more than 60,000 employees operating globally and a market capitalization of $39.5 billion. The company develops products and services across medical essentials, connected care, biopharma systems and interventional segments, generating $22.2 billion in revenue over the last twelve months.According to InvestingPro data, BD has raised its dividend for 55 consecutive years and maintains a "GOOD" financial health score. The company offers a dividend yield of 2.93%, reflecting its commitment to shareholder returns. Want deeper insights? BD is one of 1,400+ US equities covered by comprehensive Pro Research Reports, available exclusively on InvestingPro.
In other recent news, Becton Dickinson reported its Q2 2026 earnings, exceeding analyst expectations. The company achieved an adjusted earnings per share (EPS) of $2.90, surpassing the forecasted $2.78. Revenue also slightly exceeded projections, reaching $4.7 billion compared to the anticipated $4.67 billion. These earnings results highlight Becton Dickinson’s strong financial performance in the recent quarter. The positive earnings report reflects the company’s ability to perform above market expectations. Additionally, the financial community has taken note of these developments, with analysts closely monitoring the company’s performance. While no specific analyst upgrades or downgrades were mentioned, the earnings results are likely to influence future assessments. Investors are advised to consider these recent developments when evaluating Becton Dickinson’s financial health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.